Clorox Reports Second-Quarter Fiscal Year 2019 Results, Confirms Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Clorox (CLX) PT Raised to $171 at Citi
February 5, 2019 7:01 AM ESTCiti analyst Wendy Nicholson raised the price target on Clorox (NYSE: CLX) to $171.00 (from $169.00) while maintaining a Neutral rating following model updates.
Nicholson maintained FY19 EPS estimate of $6.30. She also maintained FY20 EPS estimate of $6.70 and FY21 EPS estimate of $7.10.
... More
Clorox (CLX) PT Raised to $139 at RBC Capital
February 5, 2019 6:50 AM ESTRBC Capital analyst Nik Modi raised the price target on Clorox (NYSE: CLX) to $139.00 (from $134.00) while maintaining a Sector Perform rating.
... MoreClorox (CLX) Tops Q2 EPS by 10c, Revenues Beat; Confirms FY19 EPS Mid-Point Guidance Below Consensus
February 4, 2019 6:32 AM ESTClorox (NYSE: CLX) reported Q2 EPS of $1.40, $0.10 better than the analyst estimate of $1.30. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.47 billion.
Fiscal Second-Quarter Results
Following is a summary of key second-quarter results. All comparisons are with the second... More
